Martin Lundblad (Former)
21 – 30 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Role of striatal l-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.
- Contribution to journal › Article
-
Mark
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
- Contribution to journal › Article
- 2005
-
Mark
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
- Contribution to journal › Article
-
Mark
Chapte B7 - Utility of 6-hydroxydopamine lesioned rats in the preclinical screening of novel treatments for Parkinson disease
(2005) p.193-208
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2004
-
Mark
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.
- Contribution to journal › Article
-
Mark
Modelling parkinsonian akinesia and dyskinesia in dopamine depleted rodents
(2004)
- Thesis › Doctoral thesis (compilation)
-
Mark
Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia
- Contribution to journal › Article
-
Mark
Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy)
- Contribution to journal › Article
- 2003
-
Mark
Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia.
- Contribution to journal › Article
- 2002
-
Mark
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.
- Contribution to journal › Article
